Skip to main content
. 2019 Jul;47(7):743–752. doi: 10.1124/dmd.119.086470

Fig. 4.

Fig. 4.

Observed (markers) and model prediction (lines) of THC concentration–time profiles in the (A) absence and (B) presence of sulfaphenazole, 11-OH-THC formation in the (C) absence, and (D) presence of sulfaphenazole, 11-OH-THC depletion by P450 enzymes in the (E) absence and presence of (F) sulfaphenazole and (G) itraconazole, (H) 11-OH-THC depletion by UGT enzymes, and (I) COOH-THC formation in the absence of inhibitors. Additional goodness-of-fit graphs are shown in Supplemental Fig. 3.